XML 33 R23.htm IDEA: XBRL DOCUMENT v3.19.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2018
Schedule of Fair Value of Assumptions

The fair value of options granted during the years ended December 31, 2018 and 2017 were estimated using the following weighted-average assumptions:

 

    For the Years Ended December 31,  
    2018     2017  
Exercise price   $ 2.05     $ 1.85  
Expected stock price volatility     78 %     79 %
Risk-free rate of interest     2.68 %     1.61 %
Term (years)     4.0       3.1  

Schedule of Warrants Outstanding

A summary of the status of the Company’s outstanding warrants as of December 31, 2018 and 2017 and changes during the year then ended are presented below:

 

    Number of Warrants     Weighted Average
Exercise Price
    Total Intrinsic Value     Weighted Average Remaining Contractual
Life (in years)
 
Outstanding as of December 31, 2016     3,271,875     $ 1.02     $ 2,000,000       3.9  
Issued     1,472,417       1.72       1,666,000       5.0  
Outstanding as of December 31, 2017     4,744,292     $ 1.24     $ 7,884,000       3.6  
Issued     1,053,000       1.98       -       4.2  
Exercised     (1,000,000 )     0.20       1,680,000       -  
Outstanding as of December 31, 2018     4,797,292     $ 1.62     $ 340,000       3.1  
Warrants exercisable as of December 31, 2018     4,547,292     $ 1.64     $ 340,000       3.0  

Schedule of Stock-based Compensation Expense

Stock-based compensation expense for the years ended December 31, 2018 and 2017 was comprised of the following (in thousands):

 

    For the Year Ended December 31,  
    2018     2017  
Employee stock option awards   $ 2,852     $ 2,423  
Non-employee option awards     (572 )     1,766  
Non-employee warrants     40       249  
Total compensation expense   $ 2,320     $ 4,438  

Employee Stock Option Awards [Member]  
Schedule of Stock Options, Activity

A summary of option activity under the Company’s employee stock option plan for years ended December 31, 2018 and 2017 are presented below:

 

    Number of Shares     Weighted Average
Exercise Price
    Total Intrinsic
Value
    Weighted Average Remaining Contractual
Life (in years)
 
Outstanding as of December 31, 2016     1,575,000     $ 0.50     $ 1,264,000       4.7  
Employee options granted     4,150,000       1.85       4,160,000       4.5  
Exercised     (6,000 )     1.08       11,000       -  
Forfeited     (50,000 )     1.85       6,000       -  
Outstanding as of December 31, 2017     5,669,000       1.48       7,793,000       4.3  
Employee options granted     7,610,000       2.06       -       6.3  
Exercised     (100,000 )     0.20       152,000       -  
Expired     (250,000 )     0.10       443,000       -  
Forfeited     (300,000 )     1.25       -       -  
Outstanding as of December 31, 2018     12,629,000     $ 1.87     $ 357,000       5.2  
Options vested and expected to vest as of December 31, 2018     12,629,000     $ 1.87     $ 357,000       5.2  
Options vested and exercisable as of December 31, 2018     3,654,000     $ 1.50     $ 357,000       3.6  

Non-Employee Stock Option Awards [Member]  
Schedule of Stock Options, Activity

A summary of the activity of options that the Company granted to non-employees for the year ended December 31, 2018 and 2017 are presented below:

 

    Number of Shares     Weighted Average
Exercise Price
    Total Intrinsic Value     Weighted Average
Remaining Contractual
Life (in years)
 
Outstanding as of December 31, 2016     2,955,000     $ 0.27     $ 3,053,000       3.2  
Non-employee options granted     250,000       1.95       225,000       4.6  
Outstanding as of December 31, 2017     3,205,000       0.40       7,847,000       2.4  
Non-employee options granted     200,000       1.64       -       3.7  
Exercised     (10,000 )     0.20       22,000       -  
Expired     (300,000 )     0.15       491,000       -  
Outstanding as of December 31, 2018     3,095,000     $ 0.51     $ 1,567,000       1.7  
Options vested and expected to vest as of December 31, 2018     3,095,000     $ 0.51     $ 1,567,000       1.7  
Options vested and exercisable as of December 31, 2018     2,645,000     $ 0.51     $ 1,339,000       1.7